General Announcement::Announcement by TMC Life Sciences Berhad - Q3 2024 Results Announcement

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$120M5.5%N280531 - SGXF52537366 - V2AB
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED S$155M5.25%N270513 - SGXF30304939 - HUHB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
23-May-2024 18:16:23
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Berhad - Q3 2024 Results Announcement
Announcement Reference
SG240523OTHR9STR
Submitted By (Co./ Ind. Name)
Dr Melvin Heng Jun Li
Designation
Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below)
Pls refer to the attached.

Attachments

TMCLS announcement_Q3 2024-Mar 24.pdf
Total size =276K